Almirall Reports 8.3% Increase in 9M Net Sales Driven by European Dermatology
Almirall, S.A. has reported its financial results for the first nine months of the year, highlighting a strong performance with net sales reaching €889 million. This represents an 8.3% increase compared to the same period last year, primarily fueled by robust growth within its European dermatology segment. The company also demonstrated improved operational efficiency, reporting an EBITDA of €222 million. This resulted in an expanded EBITDA margin of 24.9%, up from the previous period. Growth was further supported by strong performance in key biologic drivers.
